Showing 41 - 60 results of 27,540 for search '(( 50 ((ms decrease) OR (a decrease)) ) OR ( 100 ((ns decrease) OR (nn decrease)) ))', query time: 0.80s Refine Results
  1. 41
  2. 42
  3. 43

    Data-Driven Tool for Cross-Run Ion Selection and Peak-Picking in Quantitative Proteomics with Data-Independent Acquisition LC–MS/MS by Binjun Yan (17310633)

    Published 2023
    “…Proteomics provides molecular bases of biology and disease, and liquid chromatography–tandem mass spectrometry (LC–MS/MS) is a platform widely used for bottom-up proteomics. …”
  4. 44
  5. 45
  6. 46

    Downregulation of TRIM37 expression exacerbates pathological damage in the MS model. by Lai Jiang (2401513)

    Published 2025
    “…Scale bar = 50 μm. (h) qRT-PCR (n = 6) and <b>(i, j)</b> Western blot (n = 3) both showed a significant decrease in the <i>TRIM37</i> mRNA and protein levels in the LPC-induced MS model compared to the control group. * <i><i>P</i></i> < 0.05, ** <i><i>P</i></i> < 0.01, *** <i><i>P</i></i> < 0.001, **** <i><i>P</i></i> < 0.0001, ns = not significant.…”
  7. 47

    ku0063794 but not rapamycin decreased the TRPC6 mRNA levels in podocytes. by Fangrui Ding (659863)

    Published 2014
    “…<p>(A) ku0063794 (2 µmol/l) or rapamycin (50 nmol/l) was applied to evaluate the effects of mTORC1 and mTORC2 on TRPC6 in podocytes. …”
  8. 48
  9. 49
  10. 50
  11. 51

    Pre-treatment LLM, month of start and end of sustained (≥ 4 months) decrease in LLM by ≥ 50% from pre-treatment LLM, to < 8100 mf/ml or < 30000 mf/ml by treatment arm for participants with a sustained decrease by ≥ 50%. by Joseph Kamgno (81039)

    Published 2016
    “…<p>Pre-treatment LLM, month of start and end of sustained (≥ 4 months) decrease in LLM by ≥ 50% from pre-treatment LLM, to < 8100 mf/ml or < 30000 mf/ml by treatment arm for participants with a sustained decrease by ≥ 50%.…”
  12. 52
  13. 53
  14. 54

    Backbone RMSD of mutant D314N throughout a 100ns MD simulation. by Bruna Baumgarten Krebs (3153162)

    Published 2016
    “…<p>To confirm that mutant D314N stayed stable with an RMSD of 0.6nm, we carried a 100ns MD simulation. The mutant seemed to stabilize at 12ns with an RMSD of 0.5nm, but an increase is noticeable at 40ns, when the backbone RMSD achieves 0.6nm. …”
  15. 55
  16. 56
  17. 57
  18. 58
  19. 59
  20. 60